METTL16-dependent m⁶A enrichment and GLS1 transcript stability are associated with glutamine-related metabolic changes in hemangioma-derived cells

Food Science of Animal Resources · Springer Nature · 2026-11-16 · DOI: 10.1007/s13205-026-05144-9

Аннотация

Deciphering how epitranscriptomic regulation coordinates metabolic adaptation requires integrated strategies that connect RNA modification with metabolic and functional phenotypes. Here, we established a systematic framework combining genetic perturbation, N⁶-methyladenosine (m⁶A) analysis, GLS1 expression assessment, metabolic profiling, and pharmacological validation to interrogate RNA modification–metabolism coupling in hemangioma cells. Using this framework, we examined a putative methyltransferase-like protein 16 (METTL16)–m⁶A–glutaminase 1 (GLS1) relationship associated with glutamine-related metabolic changes. METTL16 depletion markedly reduced DNA synthesis activity, with 5-ethynyl-2′-deoxyuridine (EdU)-positive cells decreasing from approximately 70% to 22–23%, and was accompanied by lower steady-state adenosine triphosphate (ATP) levels. METTL16 loss was associated with decreased GLS1 mRNA m⁶A enrichment and reduced GLS1 mRNA expression to 13–18% of control levels; GLS1 promoter-reporter activity also declined. In pharmacological experiments, METTL16 overexpression partially alleviated the measured metabolite and growth-related changes associated with GLS1 inhibition. Collectively, these findings are consistent with METTL16-associated changes in GLS1 expression, RNA methylation, and glutamine-related metabolic status, although effects on GLS1 transcript decay remain to be established. Direct methylation of GLS1 by METTL16, glutamine metabolic flux, and therapeutic relevance require further investigation.

Читать у издателя →

Похожие статьи